Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNJ5 | P48544 | 7/20 | 0.56 |
| ▸ | KCNJ3 | P48549 | 7/20 | 0.56 |
| ▸ | KCNJ6 | P48051 | 3/20 | 0.51 |
| ▸ | CLK2 | P49760 | 1/20 | 0.50 |
| ▸ | PRKX | P51817 | 1/20 | 0.50 |
| ▸ | CAMK2D | Q13557 | 1/20 | 0.50 |
| ▸ | PKN2 | Q16513 | 1/20 | 0.50 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.50 |
| ▸ | STK17A | Q9UEE5 | 1/20 | 0.50 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.46 |
| ▸ | ANO1 | Q5XXA6 | 2/20 | 0.45 |
| ▸ | GLS | O94925 | 1/20 | 0.45 |
| ▸ | ROCK2 | O75116 | 3/20 | 0.44 |
| ▸ | ROCK1 | Q13464 | 2/20 | 0.44 |
| ▸ | P2RX4 | Q99571 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | THRB | P10828 | 1/20 | 0.43 |
| ▸ | NPC1 | O15118 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26186446 | 1.00 | KCNJ5 (0.56) | KCNJ5KCNJ3KCNJ6CLK2PRKX | |
| SCHEMBL26186450 | 0.91 | KCNJ5 (0.50) | KCNJ5KCNJ3KCNJ6CLK2PRKX | |
| SCHEMBL30285528 | 0.91 | KCNJ5 (0.50) | KCNJ5KCNJ3KCNJ6CLK2PRKX | |
| SCHEMBL30285655 | 0.89 | KCNJ5 (0.53) | KCNJ5KCNJ3KCNJ6CLK2PRKX | |
| SCHEMBL26186453 | 0.89 | KCNJ5 (0.53) | KCNJ5KCNJ3KCNJ6CLK2PRKX | |
| SCHEMBL30285791 | 0.89 | KCNJ5 (0.49) | KCNJ5KCNJ3KCNJ6CLK2PRKX | |
| SCHEMBL26186462 | 0.89 | KCNJ5 (0.49) | KCNJ5KCNJ3KCNJ6CLK2PRKX | |
| SCHEMBL30285717 | 0.88 | RECQL (0.55) | KCNJ5KCNJ3KCNJ6ANO1ROCK2 | |
| SCHEMBL26186444 | 0.88 | RECQL (0.55) | KCNJ5KCNJ3KCNJ6ANO1ROCK2 | |
| SCHEMBL30285756 | 0.88 | ROCK2 (0.44) | KCNJ5KCNJ3ROCK2ALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115996911-A | Substituted N-phenylacetamides having P2X4 receptor antagonistic activity | 拜耳公司 | 2023-04-21 | — | — | CN | claimed |
| US-20230257351-A1 | SUBSTITUTED N-PHENYLACETAMIDES HAVING P2X4 RECEPTOR ANTAGONISTIC ACTIVITY | BAYER AKTIENGESELLSCHAFT (DE) | 2023-08-17 | — | — | US | disclosed |
| CN-115996911-A | Substituted N-phenylacetamides having P2X4 receptor antagonistic activity | 拜耳公司 | 2023-04-21 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230257351-A1 | SUBSTITUTED N-PHENYLACETAMIDES HAVING P2X4 RECEPTOR ANTAGONISTIC ACTIVITY | P2RX2, P2RX5, P2RX3 | KCNJ5 452/4885KCNJ3 610/4885KCNJ6 608/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.